CNET [ChinaNet Onlines,] NT 10-K: PART II RULES 12b-25(b) AND (c) (a) The

[PART II RULES 12b-25(b) AND (c) (a) The reasons described in reasonable detail in Part III of this formuld not be eliminated without unreasonable effort or expense; x (b) (c) PART III NARRATIVE State below in reasonable detail the reasons whyForms 10-K, 20-F, 11-K, 10-Q, N-SAR, N-CSR, or the transition report or portion thereof,uld not]

By | 2016-02-08T11:23:55+00:00 March 30th, 2012|Categories: Chinese Stocks, CNET, Webplus ver|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] NT 10-K: (Original Filing)

[Skystar Bio-Pharmaceutical Company Former name if applicable: 4/F, Building B, Chuangye Square, No. 48 Keji Rd Gaoxin District, Xian, Shannxi Province, P.R. China City, state and zip code PART II -- RULES 12b-25(b) AND (c) (a) The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense; x (b) The]

By | 2016-03-01T05:26:49+00:00 April 1st, 2011|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] NT 10-K: Skystar Bio-Pharmaceutical Company Former name if applicable: 4/F,

[Skystar Bio-Pharmaceutical Company Former name if applicable: 4/F, Building B, Chuangye Square, No. 48 Keji Rd Gaoxin District, Xian, Shannxi Province, P.R. China City, state and zip code PART II -- RULES 12b-25(b) AND (c) (a) The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense; x (b) The]

By | 2016-03-01T05:28:28+00:00 April 1st, 2011|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL] NT 10-K: Skystar Bio-Pharmaceuticalmpany Former name if applicable: 4/F, Building

[Skystar Bio-Pharmaceuticalmpany Former name if applicable: 4/F, Building B, Chuangye Square, No. 48 Keji Rd Gaoxin District, Xian, Shannxi Province, P.R. China City, state and zipde PART II -- RULES 12b-25(b) AND (c) (a) The reasons described in reasonable detail in Part III of this formuld not be eliminated without unreasonable effort or expense;]

By | 2016-02-05T03:45:42+00:00 April 1st, 2011|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar